1 Kelly BJ. The diagnosis and management of neuromuscular diseases causing respiratory failure. Chest 1991;99:1485-94.

2 Roussos C. The respiratory muscles. New Engl J Med 1982;307:786-97.

3 Chevrolet JC, Deleamont P. Repeated vital capacity measurements as predictive parameters for mechanical ventilation need and weaning success in the Guillain-Barré Syndrome. Am Rev Respir Dis 1991;144:814-18.

4 Rieder P, Louis M, Jolliet P, Chevrolet JC. The repeated measurement of vital capacity is a poor predictor of the need for mechanical ventilation in myasthenia gravis. Intensive Care Med 1995;21:663-8.

5 Black LF. Maximal static respiratory pressures in generalized neuromuscular disease. Am Rev Respir Dis 1971;103:641-7.

6 Hart N, Polkey MI. Investigation of respiratory muscle function. Clin Pulm Med 2001;8:180-7.

7 David WS, Doyle JJ. Acute infantile weakness: a case of vaccine-associated poliomyelitis. Muscle Nerve 1997;20:747-9.

8 Hull HF, Birmingham ME, Melgaard B, Lee JW. Progress toward global polio eradication. Infect Dis 1997;175(suppl 1):S4-9.

9 Leis AA, Stokic DS, Polk JL, Dostrow V, Winkelmann M. A poliomyelitislike syndrome from West Nile virus infection. New Engl J Med 2002;347:1279-80.

10 Goode GB, Shearn DL. Botulism. A case with associated sensory abnormalities. Arch Neurol 1982;34:55.

11 Griffin JW, Li CY, Ho TW, et al. Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases. Brain 1995;118:577-95.

12 Hadden RDM, Cornblath DR, Hughes RAC, et al. The Plasma Exchange/ Sandoglobulin Guillain-Barré Syndrome Trial Group. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Ann Neurol 1998;44:780-8.

13 Ho TW, Mishu B, Li CY, et al. Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 1995;118:597-605.

14 Bolton CF. Critical illness polyneuropathy: a useful concept. Muscle Nerve 1999;22:419-22.

15 Sedgwick EM, Senanayake N. Pathophysiology of the intermediate syndrome of organophosphorus poisoning. J Neurol Neurosurg Psychiatry 1999;62:201-2.

16 Cavanagh JB, Fuller NH, Johnson HRM, Rudge P. The effects of thallium salts, with particular reference to the nervous system changes. Q J Med 1974;43:293-319.

17 Greenberg SA. Acute demyelinating polyneuropathy with arsenic ingestion. Muscle Nerve 1996;19:1611-13.

18 Logina I, Donaghy M. Diphtheritic polyneuropathy. A clinical study and comparison with Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 1999;67:433-8.

19 Swift TR, Rivener MH. Infectious diseases of nerve. In: Matthews WB, ed. Handbook of clinical neurology. Amsterdam: Elsevier, 1987;179-84.

20 Calderon-Gonzalez R, Rizzi-Hernandez H. Buckthorn neuropathy. N Engl J Med 1967;277:69-71.

21 Norman M, Elinder G, Finkel Y. Vincristine neuropathy and a Guillain-Barré syndrome: a case with acute lymphatic leukemia and quadriparesis. Eur J Haematol 1987;39:75-6.

22 Vital C, Vital A, Julien J, et al. Peripheral neuropathies and lymphoma without monoclonal gammopathy: a new classification. J Neurol 1990;237:177-85.

23 Ridley A. Porphyric Neuropathy. In: Dyck PJ, Thomas PK, Lambert EH, Bunge R, eds. Peripheral neuropathy. Philadelphia: Saunders, 1984;1704-16.

24 Thadani H, Deacon A, Peters T. Diagnosis and management of porphyria. Br Med J 2000;320:1647-51.

25 Mitchell G, Larochelle J, Lambert M, et al. Neurologic crises in hereditary tyrosinemia. N Engl J Med 1990;322:432-7.

26 Liyanage Y, Hoch W, Beeson D, Vincent A. The agrin/muscle-specific kinase pathway: new targets for autoimmune and genetic disorders at the neuromuscular junction. Muscle Nerve 2002;25:4-16.

27 Hughes JM, Blumenthal JR, Merson MH, Lombard GL, Dowell VR, Gangarosa EJ. Clinical features of type A and B food-borne botulism. Ann Intern Med 1981;95:442-5.

28 Swift TR. Weakness from magnesium-containing cathartics: electrophysiologic studies. Muscle Nerve 1979;2:295-8.

29 Argov Z, Kaminski HJ, Al-Mudallal A, Ruff RL. Toxic and iatrogenic myopathies and neuromuscular transmission disorders. In: Karpati G, Hilton-Jones D, Griggs RC, eds. Disorders of voluntary muscle. Cambridge: Cambridge University Press, 2001;676-88.

30 Lindesmith LA, Baines RD, Bigelow DD, Petty TL. Reversible respiratory paralysis associated with polymyxin therapy. Ann Intern Med 1968;68:318-27.

31 Senanayake N, Roman GC. Toxic neuropathies in the tropics. J Trop Geographic Neurol 1991;1:3-15.

32 Mills AR, Passmore R. Pelagic paralysis. Lancet 1988;i: 161-4.

33 Felz MW, Smith CD, Swift TR. A six-year-old girl with tick paralysis. N Engl J Med 2000;342:90-4.

34 Nicolle MW, Stewart DJ, Remtulla H, Chen R, Bolton CF. Lambert-Eaton myasthenic syndrome presenting with severe respiratory failure. Muscle Nerve 1996;19:1328-33.

35 Braun NM, Arora NS, Rochester DF. Respiratory muscle and pulmonary function in polymyositis and other proximal myopathies. Thorax 1983;38:616-23.

36 Keunen RWM, Lambregts PCLA, Op de Coul AAW, Joosten EMG. Respiratory failure as initial symptom of acid maltase deficiency. J Neurol Neurosurg Psychiatry 1984;47:549-52.

37 Trend P, Wiles CM, Spencer GT. Acid maltase deficiency in adults: diagnosis and management in 5 cases. Brain 1985;108:845-60.

38 Mohamed SD, Chapman RS, Crooks J. Hypokalaemia, flaccid quadruparesis, and myoglobinuria with carbenoxolone. Br Med J 1966;1: 1581-2.

39 Newman JH, Neff TA, Ziporin P. Acute respiratory failure associated with hypophosphatemia. N Engl J Med 1977;296:1101-3.

40 Mastaglia FL, Ojeda VJ. Inflammatory myopathies. Ann Neurol 1985;17:215-27,317-23.

41 Sitwell LD, Weinshenker BG, Monpetit V, Reid D. Complete ophthalmoplegia as a complication of acute corticosteroid- and pancuronium-associated myopathy. Neurology 1991;41:921-2.

42 Sander HW, Golden M, Danon MJ. Quadriplegic areflexic ICU illness: selective thick filament loss and normal nerve histology. Muscle Nerve 2002;26:499-505.

43 De Vere R, Bradley WG. Polymyositis: its presentation, morbidity and mortality. Brain 1975;98:637-66.

44 Dalakas MC, Karpati G. Inflammatory myopathies. In: Karpati G, Hilton-Jones D, Griggs RC, eds. Disorders of voluntary muscle. Cambridge: Cambridge University Press, 2001;636-59.

45 Pendersen J. The effect of nasotracheal intubation on the paranasal sinuses. Acta Anaesthesiol Scand 1991;35:11-13.

46 Azar I. The response of patients with neuromuscular disorders to muscle relaxants — a review. Anaesthesiology 1984;61:173-87.

47 Absalon A, Pledger D, Kong A. Adrenocortical function in critically ill patients 24 h after a single dose of etomidate. Anaesthesia 1999;54:861-7.

48 Lichtenfeld P. Autonomic dysfunction in the Guillain-Barre syndrome. Am J Med 1971;50:772-80.

49 Ropper AH, Wijdicks EFM. Blood pressure fluctuations in the dysautonomia of Guillain-Barre syndrome. Arch Neurol 1990;47:706-8.

50 Winer JB, Hughes RAC. Identification of patients at risk of arrhythmia in the Guillain-Barre syndrome. Q J Med 1988;68:735-9.

51 Hazard P, Jones C, Benitone J. Comparative clinical trial of standard operative tracheostomy with percutaneous tracheostomy. Crit Care Med 1991;19:1018-24.

52 Friedman Y, Fildes J, Mizock B, et al. Comparison of percutaneous and surgical tracheostomies. Chest 1996;110:480-5.

53 Ciaglia P. Percutaneous dilatational tracheostomy - results and long term follow-up. Chest 1992;101:464-7.

54 The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 2000;342:1301-8.

55 Maynard N. Post-operative feeding. Br Med J 1991;303:1007-8.

56 Wilmore DW. Catabolic illness - strategies for enhancing recovery. N Engl J Med 1992;325:695-702.

57 Pingleton S. Nutritional management of acute respiratory failure. JAMA 1987;257:3094-9.

58 Deitch EA. The role of intestinal barrier failure and bacterial translocation in the development of systemic infection and multiple organ failure. Arch Surg 1990;125:403-4.

59 Detsky AS. Parenteral nutrition - is it helpful? N Engl J Med 1991; 325:573-5.

60 Freeman J. Association of intravenous lipid emulsion and coagulase negative staphylococcal bacteremia in neonatal intensive care units. N Engl J Med 1990;323:301-8.

61 Stellato TA. Endoscopic intervention for enteral access. World J Surg 1992; 16:1042-7.

62 Dive A, Miesse C, Galanti L, et al. Effect of erythromycin on gastric motility in mechanically ventilated critically ill patients: a double-blind, placebo-controlled study. Crit Care Med 1995;23:1356-62.

63 Davies AR, Froomes PR, French CJ, et al. Randomized comparison of nasojejunal and nasogastric feeding in critically ill patients. Crit Care Med 2002;30:586-90.

64 Atkinson S, Sieffert E, Bihari D. A prospective randomised, double-blind, controlled clinical trial of enteral immunonutrition in the critically ill. Crit Care Med 1998;26:1164-72.

65 Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001;345:1359-67.

66 Cook D, Guyatt G, Marshall J, et al. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. N Engl J Med 1998;338:791-7.

67 Kollef M. The prevention of ventilator-associated peneumonia. N Engl J Med 1999;340:627-34.

68 Fagon J-Y. Nosocomial pneumonia in patients receiving continuous mechanical ventilation. Intensive Care Med 1989;139:877-84.

69 Ruiz-Santana S, Garcia Jimenez A, Esteban A, et al. ICU pneumonias: a multi-institutional study. Crit Care Med 1987;15:930-2.

70 Tuck RR, McLeod JG. Autonomic dysfunction in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 1981;44:983-90.

71 Tripathi M, Kaushik S. Carbamezapine for pain management in Guillain-Barré syndrome patients in the intensive care unit. Crit Care Med 2000;28:655-8.

72 Pandey CK, Bose N, Garg G, et al. Gabapentin for the treatment of pain in Guillain-Barré syndrome: a double-blinded, placebo-controlled, crossover study. Anesth Analg 2002;95:1719-23.

73 The Guillain-Barré Syndrome Study Group. Plasmapheresis and acute Guillain-Barré syndrome. Neurology 1985;35:1096-104.

74 Raphael J-C, Chevret S, Hughes RAC, Annane D. Plasma exchange for Guillain-Barré syndrome. In: Cochrane Collaboration. Cochrane Library. Issue 2. Cochrane Database of Oxford: Update Software, 2001.

75 van der Meché FGA, Schmitz PIM, Dutch Guillain-Barré Study Group. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. N Engl J Med 1992;326:1123-9.

76 Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Lancet 1997;349: 225-30.

77 Hughes RAC, Raphael J-C, Swan AV, van Doom, PA. Intravenous immunoglobulin for Guillain-Barré syndrome. In: Cochrane Collaboration. Cochrane Library. Issue 3. Oxford: Update Software, 2001.

78 Hughes RAC, van der Meché, FGA. Corticosteroid treatment for Guillain-Barré syndrome. In: Cochrane Collaboration. Cochrane Library. Issue 4. Oxford: Update Software, 2002.

79 van Doorn PA, Van Koningsveld R, Schmitz PIM, van der Meché FGA, Visser LH, Meulstee J. Randomized trial on the additional effect of methylprednisolone on standard treatment with intravenous immunoglobulin in Guillain-Barré syndrome. Neuromusc Dis 2002;12: 781-2.

80 Gajdos P, Chevret S, Clair B, Tranchant C, Chastang C. Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Ann Neurol 1997;41:789-96.

81 Gajdos P, Chevret S, Toyka K. Plasma exchange for myasthenia gravis. In: Cochrane Collaboration. Cochrane Library. Issue 4. Oxford: Update Software, 2002.

82 Cosi V, Lombardi M, Piccolo G, Erbetta A. Treatment of myasthenia gravis with high dose intravenous immunoglobulin. Acta Neurol Scand 1991; 84:81-4.

83 Arsura E, Bick A, Brunner NG, Grob D. Effects of repeated doses of intravenous immunoglobulin in myasthenia gravis. Am J Med Sci 1988; 295:438-43.

84 Arsura E. Experience with intravenous immunoglobulin in myasthenia gravis. Clin Immunol Immunopathol 1989;53:S170-9.

85 Panegyres PK, Squier M, Mills KR, Newsom-Davis J. Acute myopathy associated with large parenteral dose of corticosteroid in myasthenia gravis. J Neurol Neurosurg Psychiatry 1993;56:702-4.

86 Palace J, Newsom-Davis J, Lecky B, Myasthenia Gravis Study Group including Hughes RAC. A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Neurology 1998;50: 1778-83.

87 Mastaglia FL, Phillips BA, Zilko P. Treatment of inflammatory myopathies. Muscle Nerve 1997;20:651-64.

88 Dau PC. Plasmapheresis in idiopathic inflammatory myopathy. Experience with 35 patients. Arch Neurol 1981;38:544-52.

89 Dau PC. Plasma exchange in polymyositis and dermatomyositis. N Engl J Med 1992;327:1030-1.

90 Miller FW, Leitman SF, Cronin ME, et al. Controlled trial of plasma exchange and leukapheresis in polymyositis and dermatomyositis. N Engl J Med 1992;326:1380-4.

91 Jann S, Beretta S, Moggio M, Adobbati L, Pellegrini G. High-dose intravenous human immunoglobulin in polymyositis resistant to treatment. J Neurol Neurosurg Psychiatry 1992;55:60-2.

92 Dalakas MC, Illa I, Dambrosia JM, et al. A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med 1993;329:1993-2000.

93 Esteban A, Alia I. Clinical management of weaning from mechanical ventilation. Intensive Care Med 1998;24:999-1008.

94 Senanayave N, Johnson MK. Acute polyneuropathy after poisoning by a new organophosphate insecticide. N Engl J Med 1982;306:155-7.

95 Moore D, House I, Dixon A, et al. Thallium poisoning. Br Med J 1993;306: 1527-9.

96 Donofrio PD, Wilbourne AJ, Albers JW, Rogers L, Salanga V, Greenberg HS. Acute arsenic intoxication presenting as Guillain-Barré like syndrome. Muscle Nerve 1987;10:114-20.

97 Greenberg C, Davies S, McGowan T, Schorer A, Drage C. Acute respiratory failure following severe arsenic poisoning. Chest 1979;76:596-8.

98 Beattie AD, Briggs JD, Canavan JSF, Doyle D, Mullin PJ, Watson AA. Acute lead poisoning. Five cases resulting from self-injection of lead and opium. Q J Med 1975;44:275-84.

99 Vernay D, Dubost JJ, Thevent JP, Sauvezie B, Rampon S. "Choreé fibrillaire de Morvan" followed by Guillain-Barré syndrome in a patient receiving gold therapy. Arthritis Rheum 1986;29:1413-4.

100 Brust J CM, Hammer JS, Challenor Y, Healton EB, Lesser R. Acute generalized polyneuropathy accompanying lithium poisoning. Ann Neurol 1979;6:360-2.

101 Johnston SRD, Burn DJ, Brooks DJ. Peripheral neuropathy associated with lithium toxicity. J Neurol Neurosurg Psychiatry 1991;54:1019-20.

102 Mueller JM, Flaherty MJ. Vincristine-induced quadriparesis. South Med J 1978;71:1310-11.

103 McLeod JG. Peripheral neuropathy associated with lymphomas, leukemias, and polycythemia vera. In: Dyck PJ, Thomas PK, eds. Peripheral neuropathy. Philadelphia: Saunders, 1993;1591-8.

104 Hughes RAC, Cameron JS, Hall SM, Heaton J, Payan JA, Teoh R. Multiple mononeuropathy as the initial presentation of systemic lupus erythematosus - nerve biopsy and response to plasma exchange. J Neurol 1982;228:239-47.

105 Christie AB. Diphtheria. In: Weatherall DJ, Ledingham JGG, Warrell DA, eds. Oxford textbook of medicine. Oxford: Oxford University Press, 1987, 5.164-5.

106 Heath JW, Ueda S, Bornstein MB, Daves GD, Raine CS. Buckthorn neuropathy in vitro: evidence of a primary neuronal effect. J Neuropathol Exp Neurol 1982;41:204-20.

107 Argov Z, Mastaglia FL. Drug-induced neuromuscular disorders in man. In: Walton J, ed. Disorders of voluntary muscle. 1988;981-1014.

108 Senanayake N, Román GC. Disorders of neuromuscular transmission due to natural environmental toxins. J Neurol Sci 1992;107:1-13.

109 Warner TT, Mossman S, Murray NMF. Hypokalaemia mimicking Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 1993;56:1134-5.

110 Dalakas MC. Polymyositis, dermatomyositis, and inclusion-body myositis. N Engl J Med 1991;325:1487-98.

111 Danon MJ, Carpenter S. Myopathy with thick filament (myosin) loss following prolonged paralysis with vecuronium during steroid treatment. Muscle Nerve 1991;14:1131-9.

112 Gould DB, Sorrell MR, Lupariello AD. Barium sulfide poisoning. Arch Intern Med 1973;132:891-4.

Reducing Blood Pressure Naturally

Reducing Blood Pressure Naturally

Do You Suffer From High Blood Pressure? Do You Feel Like This Silent Killer Might Be Stalking You? Have you been diagnosed or pre-hypertension and hypertension? Then JOIN THE CROWD Nearly 1 in 3 adults in the United States suffer from High Blood Pressure and only 1 in 3 adults are actually aware that they have it.

Get My Free Ebook

Post a comment